Skip to content

Fall Risk After Conservative and Surgical Treatment of Minimally Displaced Acetabular Fractures in Geriatric Patients”

Fall Risk After Conservative and Surgical Treatment of Minimally Displaced Acetabular Fractures in Geriatric Patients” - SGA

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00041014
Enrollment
84
Registered
2026-07-17
Start date
2026-09-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Minimally displaced geriatric acetabular fractures

Interventions

Group 1: Operative treatment by percutaneous screw fixation Patients allocated to the intervention group undergo operative stabilization of minimally displaced geriatric acetabular fractures by percu

Sponsors

BG Klinik Ludwigshafen
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Age = 65 years. 2. Radiologically confirmed minimally displaced geriatric acetabular fracture with a fracture gap and/or an articular step-off of < 5 mm. 3. Fracture resulting from low-energy trauma (e.g., a fall from standing height or a low-level fall). 4. Eligibility for both operative treatment by percutaneous screw fixation and conservative management. 5. Conservative treatment followed by pain-adapted full weight-bearing of the affected side according to the study protocol. 6. Ability to provide freely given and informed written consent following oral and written information regarding the objectives, procedures, and potential risks of the study. 7. Clinical equipoise confirmed by interdisciplinary specialist assessment, indicating that both operative treatment by percutaneous screw fixation and conservative management are considered equally appropriate and medically justifiable treatment options.

Exclusion criteria

Exclusion criteria: 1. Inability to provide informed consent due to severe dementia, cognitive impairment, or psychiatric disorders precluding a full understanding of the study and the provision of informed consent. 2. Bedridden status or inability to ambulate independently prior to the fracture event. 3. Severe visual or hearing impairment substantially interfering with the safe performance of the functional assessments or communication during the study procedures. 4. Pre-existing medical conditions or previous surgical interventions substantially affecting balance or gait (e.g., neurological disorders, vestibular disorders, previous joint replacement surgery, or surgery of the lower extremities). 5. Dependence on walking aids due to causes other than the current fracture (e.g., chronic musculoskeletal disorders or degenerative joint diseases). 6. Concomitant injuries of the lower extremities limiting walking, standing, or participation in the functional assessments.

Design outcomes

Primary

MeasureTime frame
Overall fall risk assessed 3 months after treatment initiation using a multidimensional fall risk score (range 1–11 points) combining standardized patient-reported measures of subjective fall risk and objective functional performance tests (Timed Up and Go Test, modified Timed Up and Go Test, 4-Stage Balance Test, Functional Reach Test, 5 Chair Rise Test, and gait analysis using the GaitRite® system). Higher scores indicate a higher risk of falling.

Secondary

MeasureTime frame
* Pain intensity 3 months after treatment initiation, assessed using the Numeric Analog Scale (NAS; 0–10 points). * Functional outcome 3 months after treatment initiation, assessed using the Lower Extremity Functional Scale (LEFS) and the Berg Balance Scale (BBS). * Radiological outcome 3 months after treatment initiation, including fracture healing, fracture displacement, joint congruency, implant position, and implant integrity. * Occurrence and number of fall events within the first 3 months after treatment initiation. * Patient- and treatment-related parameters, including complications, rehospitalizations, rehabilitation measures, length of hospital stay, pre-traumatic mobility, and comorbidities.

Countries

Germany

Contacts

Public ContactFelix Metzger

BG Klinik Ludwigshafen

felix.metzger@bgu-ludwigshafen.de+4962168108113

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Aug 10, 2026